CorMedix
CRMD
30 hedge funds and large institutions have $8.39M invested in CorMedix in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
4% more capital invested
Capital invested by funds: $8.11M → $8.39M (+$286K)
0.08% less ownership
Funds ownership: 2.61% → 2.53% (-0.08%)
21% less funds holding
Funds holding: 38 → 30 (-8)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
98% less call options, than puts
Call options by funds: $11K | Put options by funds: $542K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.39M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$75.1K |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
+$60.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$50.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$241K |
| 2 |
ST
Spot Trading
Chicago,
Illinois
|
-$134K |
| 3 |
Goldman Sachs
New York
|
-$54K |
| 4 |
GLRA
Gerald L. Ray & Associates
Dallas,
Texas
|
-$22.9K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$18.6K |
CRMD Hedge Fund Activity: Q1 2017 in Review
30 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2017, worth a combined $8.39M — up 3.5% from $8.11M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRMD and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was BlackRock, opening a new position worth an estimated $1.39M. The largest seller was Group One Trading, cutting an estimated $241K.
- 30 institutional investors held CorMedix (CRMD) as of Q1 2017, down from 38 in Q4 2016.
- Funds reported $8.39M of CorMedix stock for Q1 2017, up 3.5% quarter-over-quarter.
- 3 funds opened new CorMedix positions in Q1 2017 and 6 closed out, a net change of -3 holders.
- The largest CorMedix buyer in Q1 2017 was BlackRock, an estimated $1.39M added.
- The largest CorMedix seller in Q1 2017 was Group One Trading, an estimated $241K sold.
Based on aggregated 13F filings for Q1 2017.